SXTPNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SXTPW
60 DEGREES PHARMACEUTICALS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.83−0.03 (-3.29%)
Close on Oct 19, 2026
- Market cap
- $2.20M
- P/E (TTM)
- –
- Dividend yield
- –
60 DEGREES PHARMACEUTICALS, INC. revenue by segment
By business segment
By product or service
| Revenue | FY2023 | FY2022 | % of revenue | YoY |
|---|---|---|---|---|
| Product Revenues net of Discounts and Rebates | $253.57K | $192.91K | 100.0% | +31.4% |
| Service Revenues | – | $30.30K | – | – |
By region
From the segment and revenue-disaggregation notes of 60 Degrees Pharmaceuticals's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.